Russell Margolis is a Psychiatry physician affiliated with Johns Hopkins University. OpenAlex indexes 52 publications with 3,527 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-5104Registry record last updated 8 Jul 2007.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic100%Quetiapine Fumarate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
20 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:
- Advanced MR imaging at 7T of neurovascular abnormalities across the life span of individuals with schizophrenia
Johns Hopkins University
FY2026$807,893R01MH141218 - Interdisciplinary Training in Psychiatry and Neuroscience
Johns Hopkins University
FY2024$349,509T32MH015330 - Interdisciplinary Training in Psychiatry and Neuroscience
Johns Hopkins University
FY2023$405,516T32MH015330
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of life
Journal of Psychiatric Research
2026 - Ultra-Treatment-Resistant Schizophrenia: Unmet Needs and a Critical Opportunity for Discovery
Schizophrenia Bulletin
2026 - Connection Learning Healthcare System Hub of the Early Psychosis Intervention Network: Program and Participant Characteristics
Early Intervention in Psychiatry
2025 - Clozapine as a Long-Term Therapeutic Choice: Longitudinal Analysis of Schizophrenia Symptoms in a Naturalistic Setting
Schizophrenia Bulletin Open
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”